DIVIS LABORATORIES
|
The Current P/E Ratio of DIVIS LABORATORIES is 70.26.
Share Price | ₹6,102.3 | Sep 18,2025 |
Market Cap | ₹162,014.7 Cr | |
Earnings-TTM | ₹2,306.0 Cr | TTM-Consolidated Results |
Price/Earnings | 70.26x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of DIVIS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹162,014.7 Cr] as on Sep 18,2025
(/) Earnings [ ₹2,306.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 70.26x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay 70.26 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DIVIS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DIVIS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DIVIS LABORATORIES
PE Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 51.17x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 48.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 69.83x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 39.49x.
How does DIVIS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
DIVIS LABORATORIES | 2,306.00 | 70.26 | 162,014.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.00 | 395,626.0 |
CIPLA LTD | 5,406.81 | 23.58 | 127,494.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.30 | 120,718.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 19.27 | 110,374.0 |
MANKIND PHARMA LTD | 1,905.51 | 57.15 | 108,892.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.74 | 105,443.0 |
LUPIN LTD | 3,722.18 | 25.11 | 93,452.0 |
AUROBINDO PHARMA LTD | 3,417.93 | 19.18 | 65,543.5 |
ABBOTT INDIA LTD | 1,452.29 | 45.24 | 65,708.5 |
ALKEM LABORATORIES LTD | 2,334.08 | 28.07 | 65,507.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DIVIS LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.18x |
Max industry PE | 70.26x |
Median industry PE | 28.07x |
Average industry PE | 37.17x |
You may also like the below Video Courses